Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
29.6M
-
Shares change
-
+2.7M
-
Total reported value, excl. options
-
$252M
-
Value change
-
+$21.7M
-
Put/Call ratio
-
8.99
-
Number of buys
-
38
-
Number of sells
-
-32
-
Price
-
$8.52
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2016
93 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q1 2016.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.6M shares
of 159M outstanding shares and own 18.62% of the company stock.
Largest 10 shareholders include FMR LLC (6.03M shares), RA CAPITAL MANAGEMENT, LLC (4.53M shares), BRIDGER MANAGEMENT, LLC (3.35M shares), UBS ASSET MANAGEMENT AMERICAS INC (2.02M shares), BAKER BROS. ADVISORS LP (2M shares), Sectoral Asset Management Inc (1.52M shares), VANGUARD GROUP INC (1.33M shares), STATE STREET CORP (1.18M shares), BlackRock Fund Advisors (982K shares), and BlackRock Institutional Trust Company, N.A. (927K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.